Oncology & Hematology Coding Alert
Indications, Formulations, Dosage and Administration of Pembrolizumab and Ramucirumab
Published on Wed Feb 24, 2016
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
Other Articles in this issue of
Oncology & Hematology Coding Alert
- 2016 Update:
Understand These Basics Before You Can Bill for Advance Care Planning
Submit codes 99497 and +99498 on the same date as chronic care management, and in [...] - Beneficiaries Seek Benefits In Advance Care Planning Services
Last year, the Kaiser Family Foundation conducted a survey prior to the release of final [...] - Screening Refresher:
G0472: Do Not Miss Payment For Hepatitis C Screening
Reserve repeat annual screening only for the high risk patients. When your physician screens a [...] - HCPCS Update:
Update How You Report Keytruda® and Cryamza, Thanks to 2016 Changes
Prepare to include J9271 and J9308 in the list of your chemo codes. Here are [...] - Indications, Formulations, Dosage and Administration of Pembrolizumab and Ramucirumab
Pembrolizumab Indications: Pembrolizumab is used in metastatic NSCLC that expresses PD-L1 and whose disease progressed [...] - You Be the Coder:
Confirm Severity When Coding Dysplasia of the Prostate
Question: Our physician documented dysplasia of prostate for an elderly patient. How can we report this [...] - Reader Question:
Submit Only One Code for Infusion, Injection, and Hydration
Question: It is possible to bill for non-chemo infusion 96365 and 96367 and hydration therapy 96360 [...] - Reader Question:
Submit 1 unit of J3430 for Every mg of Vitamin K
Question: In a patient with bleeding disorder, our physician administered an injection of vitamin K. How [...] - Reader Question:
Procedure Codes Include Preparation
Question: In a patient planned for a biopsy, our physician did an evaluation for about 20 [...]
View All
